<DOC>
	<DOCNO>NCT01141413</DOCNO>
	<brief_summary>The purpose study describe infliximab abatacept dose pattern ( i.e. , dose amount frequency ) cost among population manage care enrollee RA . This study also identify change infliximab abatacept dose time implication change may cost medication administration .</brief_summary>
	<brief_title>Dose Escalation With Remicade® Orencia®</brief_title>
	<detailed_description>This study conduct two part . The primary analysis longitudinal analysis , patient ' health care claim period patient continuously enrol health plan use evaluate primary outcome ( i.e. , dose escalation ) . The second analysis cross-sectional , patient ' health care claim fix period time ( i.e. , 2008 ) use examine health care cost . The final enrollment longitudinal portion study 2,001 ( 1,306 infliximab 695 abatacept patient ) . Final enrollment cross-sectional portion 3,450 ( 2,646 infliximab 806 abatacept patient ) . There may overlap number .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Commercial health plan enrollees medical pharmacy coverage At least 3 claim separate day infliximab ( HCPCS J1745 ) abatacept ( HCPCS C9230 , J0129 , J3590 ) administration subject identification period The 3 initial claim abatacept occur within 6week period inclusive index date three initial claim infliximab occur within 9week period inclusive index date Presence diagnosis RA ( ICD9CM 714.xx ) Continuous enrollment baseline followup period At least 18 year age old index date Prior exposure index medication baseline period Diagnosis psoriasis ( ICD9CM 696.1 ) , psoriatic arthritis ( 696.0 ) , ankylose spondylitis ( 720.0 ) , Crohn 's disease ( 555.x ) , ulcerative colitis ( 556.x ) position time study period Exposure alefacept ( HCPCS J0215 , C9211 , C9212 ) efalizumab ( HCPCS S0162 ) time study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>